Search
Search Results
##search.searchResults.foundPlural##
-
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
717PDF: 445HTML: 86 -
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE IN EGYPTIAN CHILDREN
1720PDF: 798HTML: 1124Cover: 167 -
-
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4100PDF: 1484HTML: 419 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1846PDF: 762HTML: 204 -
IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis
907PDF: 655HTML: 209 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2240PDF: 933HTML: 7603Untitled: 253Fig2: 160Fig3: 141Fig4: 159 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3949PDF: 1509HTML: 791 -
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
885PDF: 323HTML: 161 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3151PDF: 1905HTML: 7450 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
804PDF: 402HTML: 61 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2522PDF: 1026HTML: 94 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3414PDF: 2320HTML: 1401 -
-
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1334PDF: 900HTML: 280 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1189PDF: 449HTML: 18539Figure 1: 151Figure 2: 132Figure 3: 152Figure 4: 184Figure 5: 152 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7179PDF: 2343HTML: 1697Table 1.: 181Table 2.: 197Table 3.: 179Table 4.: 176 -
Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation Inflammatory marker elevation in MDS
792PDF: 614HTML: 186 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1092PDF: 451HTML: 193 -
DIAGNOSTIC VALUE OF SIMULTANEOUS MEASUREMENT OF PROCALCITONIN, INTERLEUKIN-6 AND HS CRP IN PREDICTION OF EARLY-ONSET NEONATAL SEPSIS
1927PDF: 1167HTML: 1908Untitled: 131TaBles Neinates sepsis: 153 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2074PDF: 1127HTML: 2567Study of serum haptoglobin level in thalassemia: 311Figures: 155 -
-
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
3946PDF: 1849HTML: 1740 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2002PDF: 998HTML: 15639COVER LETTER: 163 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
912PDF: 509HTML: 7793 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3082PDF: 1096HTML: 1450Untitled: 157Untitled: 147Untitled: 147 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1164PDF: 697HTML: 281 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3750PDF: 1401HTML: 8481 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3638PDF: 1404HTML: 455Figures . Eliassian: 198 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1678PDF: 636HTML: 309 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2144PDF: 920HTML: 1867 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
976PDF: 930HTML: 297







